Company Logo The global pharmacovigilance software market is projected to grow from USD 4.5 billion in 2026 to USD 12.7 billion by 2036, at a 10.9% CAGR. Growth is driven by stricter drug safety regulations, expanding clinical trials, rising adverse event data, and adoption of AI, automation, NLP and cloud platforms. North America leads the market, while Asia-Pacific will grow fastest. Key players include Oracle, IQVIA, ArisGlobal, Parexel, ICON, Veeva Systems and RxLogix. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharmacovigilance Software Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)" has been added to ResearchAndMarkets.com's offering.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.